Efficacy and Safety of Tyrosine Kinase Inhibitors in Downstaging and Palliation in Patients with Advanced Differentiated Thyroid Cancer — A Multicentre study-Reference-Cited by-同舟云学术

Efficacy and Safety of Tyrosine Kinase Inhibitors in Downstaging and Palliation in Patients with Advanced Differentiated Thyroid Cancer — A Multicentre study

Published:2024-08-09 Issue: Volume: Page:
ISSN:0975-7651
Container-title:Indian Journal of Surgical Oncology
language:en
Short-container-title:Indian J Surg Oncol

Author:

Bhat Ganesh,Chanthar Vishvak K. M. M.,Rahalkar Ashwinee,Sooraj Rizhin,Philip Ranjith Cheriyan,Mayilvaganan Sabaretnam,Singh Kul Ranjan,Chand Gyan,Ramakant Pooja^ORCID,Mishra Anjali,Agarwal Gaurav,Paul Jacob Mazhuvanchary,Mishra Anand Kumar

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13193-024-02053-2.pdf

Reference22 articles.

1. Ferlay J, Colombet M, Soerjomataram I et al (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778–789. https://doi.org/10.1002/ijc.33588

2. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306. https://doi.org/10.1056/NEJM199801293380506

3. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133. https://doi.org/10.1089/thy.2015.0020

4. Wells SA, Robinson BG, Gagel RF et al (2012) Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol 30:134–141. https://doi.org/10.1200/JCO.2011.35.5040

5. Schlumberger M, Elisei R, Müller S et al (2017) Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma. Ann Oncol 28:2813–2819. https://doi.org/10.1093/annonc/mdx479